38 research outputs found
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs
Due to its antiangiogenic and anti-immunomodulatory activity, thalidomide continues to be of clinical interest despite its teratogenic actions, and efforts to synthesize safer, clinically active thalidomide analogs are continually underway. In this study, a cohort of 27 chemically diverse thalidomide analogs was evaluated for antiangiogenic activity in an ex vivo rat aorta ring assay. The protein cereblon has been identified as the target for thalidomide, and in silico pharmacophore analysis and molecular docking with a crystal structure of human cereblon were used to investigate the cereblon binding abilities of the thalidomide analogs. The results suggest that not all antiangiogenic thalidomide analogs can bind cereblon, and multiple targets and mechanisms of action may be involved
Synthesis of seco-B-Ring Bryostatin Analogue WN‑1 via C−C Bond- Forming Hydrogenation: Critical Contribution of the B‑Ring in Determining Bryostatin-like and Phorbol 12-Myristate 13-Acetate- like Properties
*S Supporting Information ABSTRACT: The seco-B-ring bryostatin analogue, macrodiolide WN-1, was prepared in 17 steps (longest linear sequence) and 30 total steps with three bonds formed via hydrogen-mediated C−C coupling. This synthetic route features a palladium-catalyzed alkoxycarbonylation of a C2-symmetric diol to form the C9-deoxygenated bryostatin A-ring. WN-1 binds to PKCα (Ki = 16.1 nM) and inhibits the growth of multiple leukemia cell lines. Although structural features of the WN-1 A-ring and C-ring are shared by analogues that display bryostatin-like behavior, WN-1 displays PMA-like behavior in U937 cell attachment and proliferation assays, as well as in K562 and MV-4-11 proliferation assays. Molecular modeling studies suggest the pattern of internal hydrogen bonds evident in bryostatin 1 is preserved in WN-1, and that upon docking WN-1 into the crystal structure of the C1b domain of PKCδ, the binding mode of bryostatin 1 is reproduced. The collective data emphasize the critical contribution of the B-ring to the function of the upper portion of the molecule in conferring a bryostatin-like pattern of biological activity. The bryostatins are a family of marine macrolides isolated by Pettit and co-workers from the bryozoan Bugula neritina based on an assay of their anti-neoplastic activity against the P388 leukemia cell system.1 Bryostatin 1 (Figure 1), the mos
Therapeutic Antibodies to Ganglioside GD2 Evolved from Highly Selective Germline Antibodies
Antibodies play a crucial role in host defense and are indispensable research tools, diagnostics, and therapeutics. Antibody generation involves binding of genomically encoded germline antibodies followed by somatic hypermutation and in vivo selection to obtain antibodies with high affinity and selectivity. Understanding this process is critical for developing monoclonal antibodies, designing effective vaccines, and understanding autoantibody formation. Prior studies have found that antibodies to haptens, peptides, and proteins evolve from polyspecific germline antibodies. The immunological evolution of antibodies to mammalian glycans has not been studied. Using glycan microarrays, protein microarrays, cell binding studies, and molecular modeling, we demonstrate that therapeutic antibodies to the tumor-associated ganglioside GD2 evolved from highly specific germline precursors. The results have important implications for developing vaccines and monoclonal antibodies that target carbohydrate antigens. In addition, they demonstrate an alternative pathway for antibody evolution within the immune system that is distinct from the polyspecific germline pathway
Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation
Warfarin,
an important anticoagulant drug, can exist in solution
in 40 distinct tautomeric forms through both prototropic tautomerism
and ring–chain tautomerism. We have investigated all warfarin
tautomers with computational and NMR approaches. Relative energies
calculated at the B3LYP/6-311G++(d,p) level of theory indicate that
the 4-hydroxycoumarin cyclic hemiketal tautomer is the most stable
tautomer in aqueous solution, followed by the 4-hydroxycoumarin open-chain
tautomer. This is in agreement with our NMR experiments where the
spectral assignments indicate that warfarin exists mainly as a mixture
of cyclic hemiketal diastereomers, with an open-chain tautomer as
a minor component. We present a diagram of the interconversion of
warfarin created taking into account the calculated equilibrium constants
(p<i>K</i><sub>T</sub>) for all tautomeric reactions. These
findings help with gaining further understanding of proton transfer
and ring closure tautomerization processes. We also discuss the results
in the context of chemoinformatics rules for handling tautomerism